HEMATOLOGY

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

The normal lymphocytes in age 6mon to 2yrs

60%

The normal lymphocytes in age ? 60%

6mon to 2yrs

Subdivided accd to Morphology, cytochemical staining, cytogenetic studies, and T and B lymphocyte marker study

FAB CLASSIFICATION

-requires a minimum of 30% blasts for the diagnosis of AML

FAB CLASSIFICATION

FAB CLASSIFICATION-requires a minimum of ?% blasts for the diagnosis of AML

FAB CLASSIFICATION -requires a minimum of 30% blasts for the diagnosis of ?

AML

based on cellular morphology, cytochemical stains, cell markers, cytogenetics, molecular abnormalities, and clinical syndrome Minimum requirement for diagnosis: ≥ 20% marrow blast

WHO CLASSIFICATION

based on cellular morphology, cytochemical stains, cell markers, cytogenetics, molecular abnormalities, and clinical syndrome Minimum requirement for diagnosis: ?% marrow blast

≥ 20

MPO and SBB negative

ALL

MPO and SBB negative

MPO and SBB positive

AML

MPO and SBB positive

almost all blood cells, except erythroblast, show positive staining

PAS

Positive for specific esterase

M1, M2, and M3

M1, M2, and M3 Positive for ?

specific esterase

Positive for nonspecific esterase

Positive for both specific and nonspecific esterase

M4 Positive for both

specific and nonspecific esterase

Leukemia with DIC

M3 or APL

Leukemia with DIC

Most common type (85%) of childhood ALL and has the best prognosis

L1 Most common type (?%) of childhood ALL and has the best prognosis

Burkitt-type, large lymphoblast ALL

L3 ?-type, large lymphoblast ALL

Burkitt

L3 Burkitt-type, ? lymphoblast ALL

large

Leukemia Type? Lymphoma, undifferentiated

Stem cell leukemia

Leukemia Type? Lymphoma, Poorly leukemia differentiated; lymphocytic

Acute Lymphoblastic

Leukemia Type? Lymphoma, well leukemia differentiated; lymphocytic

Chronic lymphocytic

diagnostic hallmark of CML

Philadelphia chromosome (9,22)Positive

diagnostic hallmark of CML

finding of Philiadelphia Chromosome as the sole abnormality in the chronic phase of the disease is ?

good prognosis

finding of ? as the sole abnormality in the chronic phase of the disease is good prognosis

Philiadelphia Chromosome

The major intended purpose of the ? is to protect the patient and laboratory personnel

laboratory safety manual

the first step in cleanup if a blood specimen is spilled on a laboratory bench or floor area is ________ blood with disposable towels

Absorb

the most basic and effective in preventing nosocomial infections is ? between patient contacts

washing hands

Exposure to ? constitutes the major source of HIV and HBV infection in healthcare personnel

BLOOD

The transmission of ? is MORE probable than transmission of HIV

HBV

The transmission of HBV is MORE probable than transmission of ?

HIV

The value is known in a specimen similar to a patient’s whole blood or serum

Control

High in morning, low in the afternoon

Iron

ANTICOAGULANT For open heart surgery For cardiopulmonary bypass

Heparin

most widely used anticoagulant in hematology

EDTA

For paternity test

Yellow

Yellow For? WHAT TEST?

paternity test

is stable for several days

- RBC shrinkage → false low HCT, false high MCHC (Hb is not affected), and false low ESR -Platelets swell and break → false increased due to fragments - After 6 hours – RBC swells leading to increased MCV (False Macrocyte) and increase osmotic fragility

EDTA excess

→ false low HCT, false high MCHC (Hb is not affected), and false low ESR

RBC shrinkage

RBC shrinkage -> ? HCT, false high MCHC (Hb is not affected), and false low ESR

false low

RBC shrinkage -> false low HCT, ? MCHC (Hb is not affected), and false low ESR

false high

RBC shrinkage -> false low HCT, false high MCHC (? is not affected), and false low ESR

RBC shrinkage -> false low HCT, false high MCHC (Hb is not affected), and ? ESR

false low

hours – RBC swells leading to increased MCV (False Macrocyte) and increase osmotic fragility

After 6 hours

After 6 hours – RBC swells leading to ? MCV (False Macrocyte) and increase osmotic fragility

increased

After 6 hours – RBC swells leading to increased MCV (False Macrocyte) and ? osmotic fragility

increase

1 inch needle is less _______________ to patient

Frightening

?SIZE needle is less Frightening to patient

1 inch

Tourniquet application

3 to 4 inches above the puncture site

Blood culture aseptic technique:

Alcohol then Iodine (betadine)

Venipuncture angle

15 to 30o If lumabas ang 20,25,30 sa choices. I would answer 25

leakage of a small amount of blood in the tissue

Ecchymosis

leakage of a large amount of blood that leads to swelling

Hematoma

small red spots indicating that small amounts of blood have escaped into the skin

Petechiae

shooting or sharp pain, tingling, or numbness in the arm

Nerve damag

Diaphoresis, Seizure, Pain, and nerve damage

Postphlebotomy Neurologic complications

Use of Liquid tripotassium salt of EDTA: ____ decrease in HCT and RBC shrink

2 to 3%

Use of ? of EDTA: 2 to 3% decrease in HCT and RBC shrink

Liquid tripotassium salt

Use of Liquid tripotassium salt of EDTA: 2 to 3% ? in HCT and RBC shrink

decrease

Anticoagulated blood samples should be centrifuged w/__ hours of collection

object being seen in a different position by the changing the position of the head

Parallax error

Incomplete sealing Hematocrit

False decrease

Overanticoagulated hct

False decrease

short draw HCT

False decrease

hematocrit : Inadequate centrifugation

False increase

hematocrit : Allowing the tubes to stand longer after centrifugation

False increase

hematocrit : Trapped plasma

False increase

Spun hematocrit is _____% higher than electronic HCT in Trapped plasma

1 to 3%

is 1 to 3% higher than electronic HCT in Trapped plasma

Spun hematocrit

Count: 5 small square of the center

RBC

RBC Count:

5 small square of the center

Platelet

Platelet count:

25 small sq in the center

WBC

WBC count:

4 large corner squares

Pipets with clotted or blood plug should be soaked in ____soln

10% Clorox

? with clotted or blood plug should be soaked in 10% Clorox soln

Pipets

Common Components of Hematology Analyzers – aspirating unit, dispenser, diluters, etc

Hydraulics

Common Components of Hematology Analyzers – tubing system, generate vacuum and pressures

Pneumatics

Common Components of Hematology Analyzers – – controls operational sequence and computation

Electrical system

Principle: Isotonic solutions conduct electricity better than cells do

Electrical Impedance:

-number of pulse is proportional to number of cells

Electrical Impedance:

Electrical Impedance: -number of pulse is ? to number of cells

proportional

Electrical Impedance: - -? of pulse correlates the size of the cells

amplitude

-amplitude of pulse correlates the size of the cells

Electrical Impedance: -

Electrical Impedance: - - – are generated if abnormal results are generated

Flags

-Flags – are generated if abnormal results are generated

Electrical Impedance: -

RBC indices classify the anemia ________

Morphologically

? classify the anemia Morphologically

RBC indices

-Forward angle (0 degrees) = size

Light scattering method/Flow cytometry

100

-Forward angle (0 degrees) = size -Side angle/orthogonal light scatter (90o) = ?

granularity and lobularity

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前